RBAIX
Price
$28.31
Change
+$0.11 (+0.39%)
Updated
Aug 6 closing price
Net Assets
4.83B
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

RBAIX vs RLBCX

Header iconRBAIX vs RLBCX Comparison
Open Charts RBAIX vs RLBCXBanner chart's image
T. Rowe Price Balanced I
Price$28.31
Change+$0.11 (+0.39%)
VolumeN/A
Net Assets4.83B
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
RBAIX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RBAIX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RBAIX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. RBAIX (4.83B). RBAIX pays higher dividends than RLBCX: RBAIX (2.14) vs RLBCX (1.56). RBAIX was incepted earlier than RLBCX: RBAIX (10 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than RBAIX (0.52). RLBCX is a more actively managed with annual turnover of: 44.00 vs. RBAIX (39.20). RLBCX has a lower initial minimum investment than RBAIX: RLBCX (250) vs RBAIX (500000). RLBCX annual gain was more profitable for investors over the last year : 11.04 vs. RBAIX (8.57). RLBCX return over 5 years is better than : 34.79 vs. RBAIX (20.56).
RBAIXRLBCXRBAIX / RLBCX
Total Expense Ratio0.470.8953%
Annual Report Gross Expense Ratio0.520.8958%
Fund Existence10 years23 years-
Gain YTD8.6378.359103%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.83B253B2%
Annual Yield % from dividends2.141.56137%
Returns for 1 year8.5711.0478%
Returns for 3 years23.9129.8480%
Returns for 5 years20.5634.7959%
Returns for 10 yearsN/A60.65-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE1.650.01
+0.61%
Aprea Therapeutics
CFG46.64-0.29
-0.62%
Citizens Financial Group
CMPS4.31-0.05
-1.15%
COMPASS Pathways Plc
CNTB2.07-0.06
-2.82%
Connect Biopharma Holdings Limited
LRN144.05-4.27
-2.88%
Stride